Paloma Partners Management CO Eli Lilly & CO Transaction History

Paloma Partners Management CO

$3.28 Billion
Q2 2024

A detailed history of Paloma Partners Management CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Paloma Partners Management CO holds 92 shares of LLY stock, worth $83,658. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 707 86.99%

Holding current value

$83,658

Previous $550,000 84.91%

% of portfolio

0.0%

Previous 0.03%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $66,688 - $83,631	92 New	92 $83,000
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $1.62 Million - $2.17 Million	-4,624 Reduced 99.91%	4 $1,000
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $1.3 Million - $1.52 Million	4,171 Added 912.69%	4,628 $1.59 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $138,588 - $161,482	431 Added 1657.69%	457 $167,000
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $7,708 - $8,784	26 New	26 $8,000
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $883,373 - $1.1 Million	-3,764 Reduced 28.09%	9,636 $2.76 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $3.01 Million - $3.74 Million	13,400 New	13,400 $3.7 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $4.31 Million - $5.3 Million	-19,438 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $7.53 Million - $9.75 Million	-41,733 Reduced 68.22%	19,438 $4.46 Million
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $10.1 Million - $13 Million	61,171 New	61,171 $11.4 Million
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $23.1 Million - $30.5 Million	-176,854 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$146.22 - $169.13 $25.6 Million - $29.6 Million	174,943 Added 9154.53%	176,854 $26.2 Million
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $175,845 - $211,628	-1,289 Reduced 40.28%	1,911 $313,000
Q1 2020 May 15, 2020	SELL	$119.05 - $147.35 $2.21 Million - $2.74 Million	-18,568 Reduced 85.3%	3,200 $444,000
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $6.73 Million - $8.34 Million	-62,981 Reduced 74.31%	21,768 $2.86 Million
Q3 2019 Nov 14, 2019	BUY	$106.79 - $116.16 $5.25 Million - $5.72 Million	49,208 Added 138.45%	84,749 $9.48 Million
Q2 2019 Aug 14, 2019	BUY	$110.79 - $129.32 $3.46 Million - $4.04 Million	31,226 Added 723.66%	35,541 $3.94 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $8.07 Million - $9.5 Million	-72,537 Reduced 94.39%	4,315 $560,000
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $4.58 Million - $5.13 Million	43,251 Added 128.72%	76,852 $8.89 Million
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $2.88 Million - $3.61 Million	33,601 New	33,601 $3.61 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $1.07 Million - $1.23 Million	-14,109 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $780,540 - $921,376	-10,518 Reduced 42.71%	14,109 $1.09 Million
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $2.02 Million - $2.16 Million	24,627	24,627 $2.08 Million

Others Institutions Holding LLY

# of Institutions

3,887

Shares Held

763M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $864B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.

Account

Paloma Partners Management CO Eli Lilly & CO Transaction History